Quick verdict
Embla is the better pick for most patients on overall scoring. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
That said, Eden wins on specific dimensions. Eden is the highest-volume compounded-only brand outside Henry. Slick funnel, low intro pricing, lots of upsell. Quality of clinical experience is thinner than Henry or Ivim and cancellation is the most common complaint thread.
Side-by-side
| Eden | Embla | |
|---|---|---|
| Starts from | $179/mo (incl. medication) | $249/mo (+ med separate) |
| Lock-in | 3-month minimum | 12-month commitment |
| Time to prescription | 2 days | 7 days |
| Consultation type | Asynchronous | Synchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Eden | Embla | |
|---|---|---|
| Pricing transparency | 7/10 | 6/10 |
| Cancellation terms | 5/10 | 7/10 |
| Onboarding experience | 8/10 | 6/10 |
| Medication options | 5/10 | 7/10 |
| Member outcomes | 6/10 | 8/10 |
When to choose Eden
Price-led buyers willing to navigate a heavier upsell flow for an aggressive intro price.
When to choose Embla
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
FAQ
Is Eden cheaper than Embla?
Can I switch from Eden to Embla mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →